Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00973284 · ClinicalTrials.gov registry record · Phase 1
Norwalk Vaccine Study
A Phase 1 study, sponsored by Takeda.
- Completed
- Registry status
- Phase 1
- Development phase
- 98
- Enrollment target
NCT00973284 is a Phase 1 study that has completed, run by Takeda. The registered enrollment target is 98 participants.
The verdict
NCT00973284, a Phase 1 study, has completed, sponsored by Takeda.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 98 participants
- Enrollment target
Study Summary
The purpose of this study was to evaluate the efficacy of the Norwalk virus-like particle (VLP) vaccine as determined by the illness rate of viral acute gastroenteritis (AGE) during the inpatient stay.
Interventions
- BIOLOGICAL Norwalk VLP vaccine
- BIOLOGICAL mannitol and sucrose
- BIOLOGICAL Norwalk virus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2009-08-04 |
| Est. Completion | 2010-08-18 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00973284
The ClinicalTrials.gov registry entry for NCT00973284 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Takeda, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Norwalk VLP vaccine is the first listed.
NCT00973284 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00973284 about?
NCT00973284 is a clinical study titled "Norwalk Vaccine Study". The purpose of this study was to evaluate the efficacy of the Norwalk virus-like particle (VLP) vaccine as determined by the illness rate of viral acute gastroenteritis (AGE) during the inpatient stay.
What is the current status of trial NCT00973284?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 98 participants. The study started on 2009-08-04. Estimated completion is 2010-08-18.
What interventions are being tested in trial NCT00973284?
The interventions under investigation include: Norwalk VLP vaccine (BIOLOGICAL), mannitol and sucrose (BIOLOGICAL), Norwalk virus (BIOLOGICAL).
Who is sponsoring clinical trial NCT00973284?
This trial is sponsored by Takeda, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.